APA Alıntı

Mintz, R. L., Lao, Y., Chi, C., He, S., Li, M., Quek, C. H., . . . Leong, K. W. (2020). CRISPR/Cas9‐mediated mutagenesis to validate the synergy between PARP1 inhibition and chemotherapy in BRCA1‐mutated breast cancer cells. Bioeng Transl Med.

Chicago Stili Alıntı

Mintz, Rachel L., et al. "CRISPR/Cas9‐mediated Mutagenesis to Validate the Synergy between PARP1 Inhibition and Chemotherapy in BRCA1‐mutated Breast Cancer Cells." Bioeng Transl Med 2020.

MLA Alıntı

Mintz, Rachel L., et al. "CRISPR/Cas9‐mediated Mutagenesis to Validate the Synergy between PARP1 Inhibition and Chemotherapy in BRCA1‐mutated Breast Cancer Cells." Bioeng Transl Med 2020.